4142 — Adimmune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSucker Stock

Annual balance sheet for Adimmune, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,106	4,437	2,891	2,973	2,470
Net Total Accounts Receivable
Net Total Receivables	505	110	99.6	535	1,308
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,340	5,047	3,796	4,491	4,699
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,508	2,880	3,575	3,848	3,976
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	6,570	8,473	8,010	9,149	9,484
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	210	525	297	500	1,787
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,925	2,157	1,861	3,025	4,010
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	3,645	6,316	6,149	6,124	5,475
Total Liabilities & Shareholders' Equity	6,570	8,473	8,010	9,149	9,484
Total Common Shares Outstanding